BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 22, 2011
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories generics, pharmaceuticals news

Forest defeated a challenge from activist investor Carl Icahn as shareholders elected all 10 of Forest's proposed directors by a "significant margin" at the annual meeting, the company said, citing preliminary results. Icahn had nominated a slate of four directors for Forest's board. Forest said final results will be announced "promptly."

Icahn congratulated Solomon on the victory, according to a statement by the activist investor,...

Read the full 308 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >